Diabetes and heart failure: A practically oriented critical appraisal;Diabetes und Herzinsuffizienz: eine praxisorientierte, kritische Bestandsaufnahme

Deutsche Medizinische Wochenschrift

Volumn 137, Issue 9, 2012, Pages 437-441

  Halle, M ^a,j   Gitt, A K ^b   Hanefeld, M ^c   Kellerer, M ^d   Marx, N ^e   Meier, J J ^f   Schumm Draeger, P M ^g   Bramlage, P ^h   Tschoepe, D ⁱ  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d MARIENHOSPITAL STUTTGART   (Germany)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^f ST JOSEF HOSPITAL   (Germany)

^g Chirurgische Klinik Munchen Bogenhausen   (Germany)

^h Institut fur Pharmakologie und Praventive Medizin   (Germany)

ⁱ RUHR UNIVERSITY BOCHUM   (Germany)

^j Munich Heart Alliance   (Germany)

more..

Author keywords

antidiabetic treatment; diabetes mellitus; diabetic cardiomyopathy; heart failure; pathogenesis

Indexed keywords

DIABETES MELLITUS; HEART FAILURE; REVIEW;

COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; HEART FAILURE; HEART FAILURE, DIASTOLIC; HEMODYNAMICS; HUMANS; HYPOGLYCEMIC AGENTS; PROGNOSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84857392671     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0031-1298982     Document Type: Review

References (38)

1. Aguilar D, Chan W, Bozkurt B et al. Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail: 2011; 4 53 58
2. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation: 2007; 115 3213 3223 (Pubitemid 47012236)
3. Boyer JK, Thanigaraj S, Schechtman KB et al. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol: 2004; 93 870 875 (Pubitemid 38429599)
4. Courreges JP, Vilsboll T, Zdravkovic M et al. Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes. Diabet Med: 2008; 25 1129 1131
5. Dargie HJ, Hildebrandt PR, Riegger GA et al. A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure. J Am Coll Cardiol: 2007; 49 1696 1704 (Pubitemid 46589926)
6. Dickstein K, Cohen-Solal A, Filippatos G et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Eur J Heart Fail: 2008; 10 933 989
7. Edelmann F, Gelbrich G, Düngen HD et al. Exercise training improves exercise capacity, diastolic function and quality of life in patients with mild diastolic heart failure - Results of the Ex-DHF pilot study. J Am Coll Cardiol: 2011; 58 1780 1791
8. Eurich DT, Majumdar SR, McAlister FA et al. Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care: 2005; 28 2345 2351 (Pubitemid 41384275)
9. Eurich DT, McAlister FA, Blackburn DF et al. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ: 2007; 335 497
10. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev: 2004; 25 543 567 (Pubitemid 39096070)
11. Fonarow GC, Srikanthan P. Diabetic cardiomyopathy. Endocrinol Metab Clin North Am: 2006; 35 575 599, ix (Pubitemid 44335831)
12. Frye RL, August P, Brooks MM et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med: 2009; 360 2503 2515
13. Giles TD, Miller AB, Elkayam U et al. Pioglitazone and heart failure: results from a controlled study in patients with type 2 diabetes mellitus and systolic dysfunction. J Card Fail: 2008; 14 445 452 (Pubitemid 352040859)
14. Gustafsson I, Brendorp B, Seibaek M et al. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol: 2004; 43 771 777 (Pubitemid 38296474)
15. Halbirk M, Norrelund H, Moller N et al. Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure. Am J Physiol Heart Circ Physiol: 2010; 298 H1096 1102
16. Hambrecht R, Fiehn E, Weigl C et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation: 1998; 98 2709 2715 (Pubitemid 28564006)
17. Hanefeld M, Cagatay M, Petrowitsch T et al. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J: 2004; 25 10 16 (Pubitemid 38055587)
18. Hunt SA, Baker DW, Chin MH et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Circulation: 2001; 104 2996 3007 (Pubitemid 33139116)
19. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol: 1974; 34 29 34
20. Lago RM, Singh PP, Nesto RW. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet: 2007; 370 1129 1136 (Pubitemid 47464583)
21. Leung AA, Eurich DT, Lamb DA et al. Risk of heart failure in patients with recent-onset type 2 diabetes: population-based cohort study. J Card Fail: 2009; 15 152 157
22. Masoudi FA, Inzucchi SE, Wang Y et al. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation: 2005; 111 583 590 (Pubitemid 40216485)
23. Mayer J. ber den Zusammenhang des Diabetes mellitus mit Erkrankungen des Herzens. Z Klin Med: 1881; 14 212 239
24. McAlister FA, Eurich DT, Majumdar SR et al. The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy. Eur J Heart Fail: 2008; 10 703 708
25. Merck Fachinformation Glucophage. Februar 2007
26. Miche E, Herrmann G, Nowak M et al. Effect of an exercise training program on endothelial dysfunction in diabetic and non-diabetic patients with severe chronic heart failure. Clin Res Cardiol: 2006; 95 i117 i124
27. Murcia AM, Hennekens CH, Lamas GA et al. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Arch Intern Med: 2004; 164 2273 2279 (Pubitemid 39452989)
28. Nikolaidis LA, Mankad S, Sokos GG et al. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation: 2004; 109 962 965 (Pubitemid 38282847)
29. O'Connor CM, Whellan DJ, Lee KL et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA: 2009; 301 1439 1450
30. Paulus WJ, Tschope C, Sanderson JE et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J: 2007
31. Roussel R, Travert F, Pasquet B et al. Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med: 2010; 170 1892 1899
32. Rubler S, Dlugash J, Yuceoglu YZ et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol: 1972; 30 595 602
33. Scuteri A, Najjar SS, Muller DC et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol: 2004; 43 1388 1395 (Pubitemid 38496343)
34. Stratmann B, Gawlowski T, Tschoepe D. Diabetic cardiomyopathy - to take a long story serious. Herz: 2010; 35 161 168
35. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet: 1998; 352 837 853
36. Varela-Roman A, Grigorian Shamagian L, Barge Caballero E et al. Influence of diabetes on the survival of patients hospitalized with heart failure: a 12-year study. Eur J Heart Fail: 2005; 7 859 864 (Pubitemid 41125906)
37. Widlansky ME, Gokce N, Keaney JF Jr et al. The clinical implications of endothelial dysfunction. J Am Coll Cardiol: 2003; 42 1149 1160 (Pubitemid 37188333)
38. Wilkinson IB, Franklin SS, Cockcroft JR. Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension: 2004; 44 112 116 (Pubitemid 39014221)